Drawing for POPPA

USPTO serial 79215033

POPPA

Reviewed by CopyMark Law Group

Reg. 5455914Status 706Registered
Filing date
Status date
Registration date
May 1, 2018
Examiner
REID, CAILE MAUREEN
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with POPPA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Adam E. Schwartz

Adam E. Schwartz Schwartz Intellectual Property Law, PLLC244 5th Ave.#2157New York, NY 10001

Goods and services

ClassDescriptionStatusFirst use
010Portable medical specimen collection devices in the nature of collapsible container urination aids for women for the collection of urine; Fecal medical specimen collection devices in the nature of pouches for the collection of fecal matterACTIVE—
016Cardboard containers for the collection of human waste; Collapsible cardboard containers for the collection of human wasteACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 12, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Mar 12, 202571AGREGISTERED-SEC.71 ACCEPTED—
Mar 10, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 14, 2024ES71TEAS SECTION 71 RECEIVED—
Jan 4, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 7, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 14, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 14, 2018FIMPFINAL DISPOSITION PROCESSED—
Aug 1, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 1, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 24, 2018NPUBNOTICE OF PUBLICATION—
Dec 26, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 21, 2017CNEAEXAMINERS AMENDMENT MAILED—
Dec 20, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Dec 20, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 14, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 14, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 14, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 4, 2017RFNTREFUSAL PROCESSED BY IB—
Oct 18, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 18, 2017RFRRREFUSAL PROCESSED BY MPU—
Oct 18, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 17, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 10, 2017DOCKASSIGNED TO EXAMINER—
Sep 5, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 30, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 24, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance